Structures by: Tufekcic S.
Total: 12
C26H21F3N4O4S
C26H21F3N4O4S
Journal of Pharmaceutical Sciences (2008) 97, 3942-3956
a=4.7197Å b=8.8119Å c=29.6402Å
α=89° β=85° γ=81°
C20H13F3N4O2S
C20H13F3N4O2S
Journal of Pharmaceutical Sciences (2008) 97, 3942-3956
a=12.861(2)Å b=14.956(2)Å c=11.612(3)Å
α=100.76(1)° β=106.00(1)° γ=111.387(8)°
C24H19F3N4O3S
C24H19F3N4O3S
Crystal Growth & Design (2009) 9, 3 1344
a=11.917(3)Å b=12.426(3)Å c=16.430(4)Å
α=83.330(4)° β=76.227(4)° γ=78.659(4)°
C23H20F3N5O3S
C23H20F3N5O3S
Crystal Growth & Design (2009) 9, 3 1344
a=5.1022(8)Å b=10.1280(17)Å c=23.009(4)Å
α=102.072(3)° β=93.711(3)° γ=98.007(3)°
C26H26F3N5O3S
C26H26F3N5O3S
Crystal Growth & Design (2009) 9, 3 1344
a=5.2329(14)Å b=20.056(6)Å c=25.014(7)Å
α=90.00° β=93.300(6)° γ=90.00°
C26H21F3N4O3
C26H21F3N4O3
Crystal Growth & Design (2009) 9, 3 1344
a=5.2056(8)Å b=25.720(4)Å c=17.027(3)Å
α=90.00° β=93.981(3)° γ=90.00°
C23H18F3N4O4S
C23H18F3N4O4S
Crystal Growth & Design (2009) 9, 3 1344
a=10.559(2)Å b=9.528(2)Å c=22.396(5)Å
α=90.00° β=97.098(4)° γ=90.00°
C18H11F3N4OS
C18H11F3N4OS
Crystal Growth & Design (2009) 9, 3 1344
a=9.8621(15)Å b=12.9579(19)Å c=13.5512(19)Å
α=98.915(3)° β=90.638(3)° γ=93.451(3)°
C27H23F3N4O4S
C27H23F3N4O4S
Crystal Growth & Design (2009) 9, 3 1344
a=44.787(6)Å b=4.7726(6)Å c=24.110(3)Å
α=90.00° β=93.544(3)° γ=90.00°
C44H32F6N8O8S2
C44H32F6N8O8S2
Crystal Growth & Design (2009) 9, 3 1344
a=10.302(2)Å b=12.794(3)Å c=17.004(4)Å
α=104.026(4)° β=99.473(4)° γ=91.595(4)°
C20H13F3N4O
C20H13F3N4O
Crystal Growth & Design (2009) 9, 3 1344
a=10.269(2)Å b=13.135(3)Å c=13.325(3)Å
α=107.245(3)° β=98.368(4)° γ=91.498(4)°
(C20H12F3N4O2S),0.5(C3H4O4)
(C20H12F3N4O2S),0.5(C3H4O4)
Crystal Growth & Design (2009) 9, 3 1344
a=11.582(2)Å b=12.275(2)Å c=16.184(3)Å
α=97.183(4)° β=108.818(4)° γ=98.030(4)°